Tracesci Global to present track and trace solution at PharmaTech 2023

The circulation of counterfeit drugs is detrimental to the growth of the pharma industry, and adopting anti-counterfeiting measures at the manufacturing location is crucial. Tracesci advocates for the adoption of blockchain-based track and trace solutions that can provide manufacturers with 360 degrees visibility and control over their supply chains. 

The pharmaceutical industry has long been coping with the issue of counterfeit or spurious drugs, and the challenges have only been exacerbated by the disruptions caused by the Covid-19 pandemic. 

According to a recent report published by CRISIL-ASPA on the State of Counterfeiting in India 2022, industry insiders estimate that 0.1-3% of medicines manufactured and sold in India are counterfeit, while distributors and authentication solution providers believe the number could be as high as 10-20% of the overall pharmaceutical market.

“With TRACESCI, a brand can obtain an effective product authentication solution that includes tracking legitimate products throughout the supply chain, a consumer engagement app, and an efficient reporting system, all under one unique SAAS-based track and trace platform,” said Priyanka Rathi, DGM, marketing and communication at Jetsci Global & Tracesci Global.

Kunal Kothari, product manager at Tracesci Global, added, “As a global specialist in product authentication and traceability, we are successfully fortifying governments and brands alike through our intuitive, innovative blockchain-based supply chain manufacturer interface. With Tracesci, traceability is just a tap away.”